Artificial intelligence for patient safety: Pilot evaluation of LLMs for drug-drug interaction analysis
Drug–drug interactions (DDIs) represent a significant challenge in the pharmacotherapy of patients with chronic non-communi cable diseases, including cardiovascular diseases and diabetes, due to polypharmacy and increased risk of clinically relevant inter actions. Effective approaches for early DDI identification are e...